Alpha Tau Medical Ltd.
DRTS
$14.46
-$0.38-2.56%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -- | -- | 8.60% | 3.26% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 3.23% | 4.13% | |
| Operating Income | -- | -- | -3.23% | -4.13% | |
| Income Before Tax | -- | -- | -26.70% | -11.75% | |
| Income Tax Expenses | -- | -- | 714.81% | 2,700.00% | |
| Earnings from Continuing Operations | -- | -- | -27.43% | -12.12% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -27.43% | -12.12% | |
| EBIT | -- | -- | -3.23% | -4.13% | |
| EBITDA | -- | -- | -3.26% | -4.08% | |
| EPS Basic | -- | -- | -21.78% | -11.11% | |
| Normalized Basic EPS | -- | -- | -23.11% | -4.23% | |
| EPS Diluted | -- | -- | -21.78% | -11.11% | |
| Normalized Diluted EPS | -- | -- | -23.11% | -4.23% | |
| Average Basic Shares Outstanding | -- | -- | 4.48% | 0.87% | |
| Average Diluted Shares Outstanding | -- | -- | 4.48% | 0.87% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |